The present invention relates to the use of the epitope which comprises the tyrosine at position 1214 in the amino acid sequence of the vascular endothelial growth factor receptor, KDR/Flk-1, as a marker in the measurement of a change in the activation state of the KDR/Flk-1 receptor and to probes, such as antibodies, which recognize said epitope. The invention also relates to the use of KDR/Flk-1 epitope Y1214 as a marker in the detection of and/or measurement of the level of the KDR/Flk-1 receptor and to assays which utilize the use of the Y1214 epitope and to compounds derived from said assays.

 
Web www.patentalert.com

< Polynucleotides encoding C-type lectin polypeptides and methods of use thereof

> .DELTA.5 desaturase and its use in making polyunsaturated fatty acids

> Methods for treating rheumatoid arthritis using human antibodies that bind human TNF.alpha.

~ 00523